Sandra Demontigny was afraid of being a prisoner in her own body: a 45-year-old diagnosed with early-onset Alzheimer's ... she is now "relieved" after the Canadian province approved advanced ...

Voyager Therapeutics (VYGR) announced that it has selected a lead development candidate, VY1706, for its tau silencing gene therapy program in ...

Candidate VY1706 demonstrates significant reductions of tau at low doses in NHP study; IND and CTA filings anticipated in 2026 -- VY1706 is the ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.

Please can you introduce yourself, your current role within the Alzheimer's Association, and provide an overview of your career? My name is Heather Snyder. I am one of the scientists on staff at ...

It is estimated that men in the United States aged 65 years have a 19.5 percent chance of developing Alzheimer's disease during their lifetime, while the lifetime risk for women age 65 years is 21 ...

Hallucinations are a fairly common symptom in the advanced stages of Alzheimer’s disease. Treatment options like medications or therapy can help reduce their frequency and effect. Alzheimer’s ...

Jaguar has unveiled a new logo that emphasizes its posh British pronunciation as it transitions into a 'new era' that ...

Impact Link Townsend Davis, who lives in Brooklyn, New York, and his wife Bridget had been married for a decade when she was diagnosed with early-onset Alzheimer's in June 2015. She was 51 ...

The Alzheimer Society Research Program (ASRP) provides grants and awards to support research in Canada that promises new insights into causes, risk reduction, diagnosis, treatment and management of ...

In the review, Ferrer Isidro from the University of Barcelona and Reial Acadèmia de Medicina de Catalunya, explores the differences in brain aging and Alzheimer's disease between humans and their ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies ...